Predict falls due to freezing
- Trial ID
- NCT07386015
- Official Title
- FREEZE-Path Cohort: Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)
- Goal
- Predict falls due to freezing
- Status
- RECRUITING
- Sponsor
- Tianjin Huanhu Hospital
- Study Type
- OBSERVATIONAL
- Enrollment
- 700 participants
- Conditions
- Freezing of Gait, Parkinson's Disease, Parkinsonism, Vascular Parkinsonism, Idiopathic Normal Pressure Hydrocephalus (INPH)
- Interventions
- Observational Data Collection
Plain-Language Summary
The goal is to unravel why freezing of gait happens and how different causes and movement patterns predict who gets worse, so clinicians can identify distinct FOG subtypes and better predict outcomes. To do that, researchers will collect observational data from up to 700 people, including gait and balance tests, video and speech recordings, and clinical measures, then map etiology, phenotype, and outcome links without testing a treatment. Adults 30 to 85 with Parkinson's disease or related parkinsonian disorders who have freezing or other gait or balance problems and can complete assessments and give consent are eligible, while people with very severe dementia (MMSE < 10), major recent medical events, severe psychiatric or medical issues affecting gait safety, inability to follow up, or refusal of video/speech recording are excluded.
Locations
- Tianjin Huanhu Hospital, Tianjin, Tianjin Municipality, China
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Observational Data Collection. The goal is to unravel why freezing of gait happens and how different causes and movement patterns predict who gets worse, so clinicians can identify distinct FOG subtypes and better predict outcomes. To do that, researchers will collect observational data from up to 700 people, including gait and balance tests, video and speech recordings, and clinical measures, then map etiology, phenotype, and outcome links without testing a treatment. Adults 30 to 85 with Parkinson's disease or related parkinsonian disorders who have freezing or other gait or balance problems and can complete assessments and give consent are eligible, while people with very severe dementia (MMSE < 10), major recent medical events, severe psychiatric or medical issues affecting gait safety, inability to follow up, or refusal of video/speech recording are excluded.
- Who can participate?
- Participants must be between 30 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 3 years and 10 months.